Trial Information

Summary: If the patient has B-Cell Chronic Lymphocytic Leukemia and has not been treated previously for the disease with a cell-depleting aim, he/she may be eligible for this clinical trial.

Physicians are currently seeking subjects to participate in this open-labeled, randomized, two-dose, parallel group, phase II clinical research study of an investigational agent (ofatumumab). Patients in the trial will receive one of two possible doses of ofatumumab, a fully human monoclonal anti-CD20 antibody, in combination with fludarabine and cyclophosphamide.

Qualified subjects receive all study-related evaluations and procedures related to the study at no cost.

Main Inclusion Criteria:

  • Patients with active B-CLL with an indication for treatment
  • Age = 18 years

Main Exclusion Criteria:

  • Any previous treatment for B-CLL with any cell depleting aim
  • Patients who at the time of inclusion are not expected to be able to complete the ofatumumab-FC treatment
  • Current participation in any other interventional clinical study

There are additional inclusion and exclusion criteria that may be discussed with a study physician.

US Project Manager: Zena Muzyczenko 866-887-1291
International Clinical Trial Manager: Henriette Kristensen

Contact:

Zena Muzyczenko, Project Manager
UTMD Anderson Cancer Center
Dept. of Leukemia, Unit 428
Located in:
Houston, TX 77230-1402
Telephone: 866-887-1291
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:29:40 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA